Clincosm LogoSign in Get a demo

chronic obstructive pulmonary disease (copd)

Showing 1 - 25 of 328
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malnutrition, Cancer, IBD Trial in Spain (Fortimel)

Recruiting
  • Malnutrition
  • +4 more
  • Fortimel
  • Bilbao, Spain
  • +5 more
Sep 20, 2023

COPD (COPD) Trial in Worldwide (Placebo, Tozorakimab)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Sheffield, Alabama
  • +31 more
Sep 11, 2023

COPD (COPD) Trial in Lund (L-menthol, Placebo)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Lund, Sweden
    Lund University
May 24, 2023

COPD (COPD) Trial (tiotropium bromide inhalation powder (Spiriva HandiHaler), tiotropium bromide (Spiriva Respimat),

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • tiotropium bromide inhalation powder (Spiriva HandiHaler)
  • +2 more
  • (no location specified)
Apr 20, 2023

Asthma, COPD (COPD) Trial in Baltimore (CHF5993, CHF5259, Moxifloxacin 400mg)

Recruiting
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Baltimore, Maryland
    PAREXEL Baltimore Early Phase Clinical Unit
Apr 13, 2023

COPD (COPD) Trial in Worldwide (Tozorakimab, Placebo)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Tozorakimab
  • Placebo
  • Lincoln, California
  • +113 more
Feb 15, 2023

Remote Lung Auscultation in Transitions of Care After Pulmonary

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • RESP Biosensor
  • Philadelphia, Pennsylvania
  • +1 more
Jan 31, 2023

COPD (COPD) Trial in Worldwide (Tezepelumab, Placebo)

Active, not recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Tezepelumab
  • Placebo
  • Dothan, Alabama
  • +90 more
Jan 31, 2023

COPD (COPD) Trial in Worldwide (BGF MDI HFO 320/14.4/9.6 µg, BGF MDI HFA 320/14.4/9.6 µg)

Recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • BGF MDI HFO 320/14.4/9.6 μg
  • BGF MDI HFA 320/14.4/9.6 μg
  • Phoenix, Arizona
  • +96 more
Jan 23, 2023

COPD (COPD) Trial in Glendale (Treatment A, Treatment B, Treatment C)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Treatment A
  • +2 more
  • Glendale, California
    Research Site
Apr 20, 2022

COPD (COPD) Trial in Miami, Edmond (Astegolimab, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Miami, Florida
  • +1 more
Jan 18, 2023

COPD (COPD) Trial in Manchester, Nottingham, Southampton (Interferon Beta-1A, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Interferon Beta-1A
  • Placebo
  • Belfast, United Kingdom
  • +15 more
Jan 3, 2023

ValidatingUnique COPD Case Finding Tool in Primary Care (Aim 1)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • CAPTURE Tool
  • Los Angeles, California
  • +7 more
Nov 1, 2022

COPD (COPD) Trial in Guangzhou (Autologuos transplantation of bronchial basal cells)

Recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Autologuos transplantation of bronchial basal cells
  • Guangzhou, Guangdong, China
    Guangzhou Institute of Respiratory Disease, The First Affiliated
Oct 25, 2022

COPD (COPD) Trial in La Garde, Toulon (Single then dual task situation, Dual then single task situation)

Recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Single then dual task situation
  • Dual then single task situation
  • La Garde, Var, France
  • +1 more
Oct 10, 2022

Chronic Respiratory Failure With Hypercapnia, COPD (COPD), Obesity Hypoventilation Syndrome (OHS) Trial in Rennes (ETAPES

Completed
  • Chronic Respiratory Failure With Hypercapnia
  • +2 more
  • ETAPES Program
  • Rennes, France
    Arnaud PRIGENT, MD
Sep 14, 2022

COPD (COPD) Trial in Worldwide (Tozorakimab, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Sheffield, Alabama
  • +239 more
Aug 10, 2022

COPD (COPD) Trial in Worldwide (Tozorakimab, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Mobile, Alabama
  • +199 more
Aug 10, 2022

COPD (COPD) Trial (AZD4831, Placebo)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • (no location specified)
Aug 5, 2022

COPD (COPD), Chronic Bronchitis Trial in Worldwide (MEDI3506, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Chronic Bronchitis
  • MEDI3506
  • Placebo
  • Sheffield, Alabama
  • +125 more
Jul 28, 2022

ValidatingUnique COPD Case Finding Tool in Primary Care (Aim 2)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • On-site Practice Assessment
  • +4 more
  • Los Angeles, California
  • +5 more
Jul 28, 2022

COPD (COPD) Trial in United States (COPD plus CAPTURE education and patient-level information, COPD Education Only)

Active, not recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • COPD plus CAPTURE education and patient-level information
  • COPD Education Only
  • Los Angeles, California
  • +8 more
Jul 27, 2022

HIV, COPD (COPD), Emphysema Trial in New York (Doxycycline, Placebo (sugar pill))

Completed
Has Results
  • HIV
  • +2 more
  • New York, New York
    Genetic Medicine
Jul 13, 2022

COPD (COPD), Alpha1-Antitrypsin Deficiency Trial (ARALAST NP, Another Available A1PI)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Alpha1-Antitrypsin Deficiency
  • ARALAST NP
  • Another Available A1PI
  • (no location specified)
Jul 18, 2022

COPD (COPD) Trial in Manchester (Placebo Comparator, PUR1800 250 ug, PUR1800 500 ug)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Placebo Comparator
  • +2 more
  • Manchester, Wythenshawe, United Kingdom
    Medicines Evaluation Unit Ltd.
Jun 24, 2022